{"podcast":{"title":"Blood Podcast","slug":"blood-podcast-664776","podcast_index_feed_id":664776,"rss_url":"https://feeds.transistor.fm/blood-podcast","website_url":null,"image_url":"https://img.transistorcdn.com/WlMZsA1edpS0qEIavlrh9KLfCFShKE7FTJxZLlZsByw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kY2Q4/YzJhZmMwODBjOWRi/YTNhN2Y1NWJkMzMw/NTBjZi5qcGc.jpg","author":"American Society of Hematology","episode_count":388,"summary":"The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.","last_synced_at":"2026-07-17T04:20:44.828596+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776"},"episode":{"title":"New Approaches: Marstacimab Therapy and HLH Biomarkers","slug":"new-approaches-marstacimab-therapy-and-hlh-biomarkers","published_at":"2026-05-28T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/new-approaches-marstacimab-therapy-and-hlh-biomarkers","show_page_url":"https://stenobird.com/podcast/blood-podcast-664776","url":"https://share.transistor.fm/s/18f11dc5","audio_url":"https://prfx.byspotify.com/e/media.transistor.fm/18f11dc5/085b0d58.mp3","summary":"In this week's episode, Blood editor Dr. James Griffin interviews Drs. Johnny Mahlangu and Joseph Rocco on their articles published in volume 147 issue 9 of Blood . Dr. Mahlangu discusses study details and next steps from \" Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial \" which shows that bleeding was reduced by 93% with subcutaneous marstacimab. Dr. Rocco shares the development behind \" CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis \", and the insights gained from measuring a new surrogate marker of IFN-γ activity predicting severity and mortality.","meta_description":"In this week's episode, Blood editor Dr. James Griffin interviews Drs. Johnny Mahlangu and Joseph Rocco on their articles published in volume 147 issue 9…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1070,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/new-approaches-marstacimab-therapy-and-hlh-biomarkers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/new-approaches-marstacimab-therapy-and-hlh-biomarkers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}